Milk thistle
Milk thistle supplement guide: forms, labels, testing and price
Capsules, powders, tinctures and gummies all carry the name milk thistle. Here is how to tell them apart by what the label states, what testing proves and what a real dose costs.
By Artifact Editors, Editorial team
Published · 6 min read
In this article
Start with what the label actually measures
Most of the confusion in this category comes from one number: the milligrams printed on the front. Raw milk thistle seed contains a modest and variable amount of silymarin, the flavonolignan complex (led by silibinin) that the research is about. That is why the human trials used standardized extracts rather than ground seed.
A label reading 'milk thistle extract 1,000 mg' with no percentage tells you the weight of the material, not its concentration. A 250 mg capsule standardized to a high silymarin percentage can deliver more of the active complex than a 1,000 mg capsule with no stated standard. Look for a line such as 'standardized to 80% silymarin,' then do the multiplication yourself.
For background on the plant and what is known about it, see our milk thistle topic page.
The dose worth measuring against
Several human trials used 420 mg a day of silymarin. That figure appears in a small trial in people with diabetic kidney disease, in a trial in breast cancer patients on chemotherapy, and in a drug-interaction study in healthy volunteers. It is typically split into three 140 mg doses.
That is a reference point, not a recommendation, and the evidence behind it is mixed. A 2017 pooled analysis in people with liver disease found silymarin lowered ALT and AST by an amount the authors considered clinically negligible. A 2-year trial of 450 mg a day in alcoholic cirrhosis found no effect on survival. A larger trial in chronic hepatitis C found that doses up to 2,100 mg a day did not beat placebo on liver enzymes or viral levels.
Some pooled analyses are more encouraging, particularly in fatty liver disease, but their authors call for confirmation. The practical point for shopping is narrower: if a product claims to be 'research-based,' check whether a serving comes anywhere near the amounts studied, expressed as silymarin.
Forms compared
Standardized extract capsules and tablets are the form used in nearly all human research. Everything else is an extrapolation, which is not the same as being bad, but it does change how much you can verify.
| Form | What the label usually tells you | Dose predictability | Main caveat |
|---|---|---|---|
| Standardized extract capsule or tablet | Often a silymarin percentage | Highest of the group | Check the percentage and the serving size, not the capsule count |
| Phytosome (silibinin bound to phosphatidylcholine) | Silibinin amount, complex named | Good, and built for absorption | Absorption advantage shown in a 2005 review; usually costs more |
| Tincture or liquid | Rarely a silymarin percentage | Hard to compare to trial doses | No head-to-head absorption trial against capsules |
| Tea or ground seed | Seed weight only | Low and variable | Silymarin dissolves poorly in water; no trial of tea as a beverage |
| Gummy | Usually total extract, no percentage | Usually well below trial amounts | No trial has tested gummies; sugar takes a larger share of each serving |
A 2021 systematic review found that silymarin's active compounds are poorly absorbed by mouth, largely because the body processes and excretes them quickly. That limit applies to every form. The only format engineered around it is the phytosome, which a 2005 review found improved silibinin absorption compared with plain silymarin extract.
Powders, capsules and gummies, in practice
Powders. 'Powder' can mean two things. A capsule filled with powdered standardized extract is functionally the standard form. A bag of ground seed is closer to tea: you are getting whole seed with an unstated and variable silymarin content, and no trial describes what a spoonful delivers.
Capsules. These can concentrate a meaningful amount of extract in a small volume, which is why they dominate the research. Check how many capsules make up one serving. A bottle of small capsules taken three at a time empties faster than the capsule count suggests.
Gummies. A gummy has to stay chewable and palatable, which limits how much extract it can hold. Most carry less than the amounts used in trials, and many state a total extract weight without a silymarin percentage. Products vary, so read the specific label rather than assuming. Check the gelling agent too: gelatin is not vegan, while pectin typically is.
Gummies are not necessarily useless, but with no trial behind the format and a lower dose per serving, they are the hardest form to defend on evidence.
What 'third-party tested' can and cannot tell you
The phrase has no single legal definition on a supplement label. It might mean a lab confirmed silymarin content, heavy metals and microbial counts. It might also mean one lab ran one test once. Labeled and actual ingredient amounts do not always match across the supplement category, which is why the document behind the badge matters more than the badge.
- A batch-specific certificate of analysis (COA) that names what was tested (identity, silymarin content, metals, microbes) and shows a number against a limit, not just a pass logo.
- A named public standard. USP publishes monographs for milk thistle raw material, capsules, tablets and powdered extract. The raw material must contain at least 2.0% silymarin (as silybin) on a dried basis. Finished capsules and tablets must contain 90% to 110% of the silymarin amount on their own label.
- Not the same as organic. USDA organic certification covers growing and handling. It says nothing about silymarin content or potency.
A product can be tested without referencing USP, so absence of the name is not an automatic failure. Absence of any document is a different matter. For more detail on seals, see third-party tested milk thistle.
Price per effective dose, not per bottle
Divide the bottle price by the number of servings at the label's directed dose. Then divide again by the silymarin each serving delivers. A $15 bottle of 60 capsules taken one at a time is $0.25 a serving. A $28 bottle of 90 capsules taken three at a time is 30 servings, or about $0.93 each. The cheaper bottle is only cheaper if the capsules contain comparable silymarin.
Price differences usually track standardization, extraction method, phytosome formulation and testing. No dose-response trial has compared milk thistle at different amounts, so a higher price is not evidence of a stronger effect. Our price-per-serving guide walks through more examples.
Label red flags
- No silymarin percentage. A bare milligram figure cannot be converted into a dose.
- Proprietary blends. If milk thistle shares a capsule with dandelion, artichoke, turmeric or other botanicals, each should list its own amount. A combined total hides what you are getting.
- 'Detox' or 'cleanse' language. No trial has measured either in a general population. The human research looked at specific lab markers in people with diagnosed liver or kidney conditions.
- Milk supply claims. An NIH reference monograph reports no valid clinical trial support for milk thistle increasing milk supply.
- Absorption claims with no mechanism. Piperine raised silibinin availability by 146% to 181% in rats, but that is an animal and cell-line result, not a human trial. Treat 'enhanced with black pepper' as unproven for people.
- A testing badge with nothing behind it. If a COA cannot be requested or found, the claim cannot be checked.
Organic and non-GMO claims are agricultural, not potency claims. They are fine to have, but they do not substitute for a standardization percentage.
Safety checks before you buy
A 2019 safety review found silymarin generally well tolerated in humans, including at high doses for 24 weeks, with gastrointestinal upset the main limiting side effect. The NIH monograph notes occasional GI or skin reactions and rare allergic cross-reactivity in people sensitive to ragweed-family plants.
On medications, the picture is low risk but not zero. A standardized extract taken three times daily for 14 days had no significant effect on four major drug-metabolizing liver enzymes in healthy volunteers. A separate trial of 420 mg a day for 14 days changed losartan blood levels, with the effect depending on each person's CYP2C9 genotype. If you take prescription drugs or have a liver condition, mention the supplement to a pharmacist or doctor before starting.
Also read the other-ingredients line. Capsule shells, flow agents and carrier oils (often soybean oil in softgels) matter if you avoid a specific ingredient. Gelatin capsules are not vegan, while HPMC or cellulose capsules are.
Frequently asked questions
Is a phytosome milk thistle product worth the extra cost?
A 2005 review found that binding silibinin to phosphatidylcholine improved absorption compared with plain silymarin extract. That is a real formulation difference. Whether it changes outcomes in people is not established, so a plain extract with a clear standardization percentage is still a reasonable product.
Should I choose capsules or tablets?
The research does not distinguish between them. Both are standardized extract forms. Compare the silymarin per serving, the other ingredients and the testing documentation. Capsule shell material matters only if you avoid gelatin or have a specific dietary preference.
Does a higher silymarin percentage always mean a better product?
Not on its own. A higher percentage means a more concentrated extract, which affects how many capsules a serving needs. It says nothing about absorption, purity or whether the label is accurate, which is why testing documentation still matters.
Can I check a milk thistle label for accuracy myself?
Not fully. You can confirm that a silymarin percentage and serving size are stated and do the arithmetic. Verifying that the bottle contains what it claims requires a lab, which is why a batch-specific certificate of analysis or a named standard is the practical check.
Sources (14)
- Tvrdý V, et al. Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Med Res Rev. 2021.
- Kidd P, et al. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern Med Rev. 2005.
- Soleimani V, et al. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. Phytother Res. 2019.
- Milk Thistle. . 2006.
- Fallahzadeh MK, et al. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. Am J Kidney Dis. 2012.
- Moezian GSA, et al. Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial. J Oncol Pharm Pract. 2022.
- Han Y, et al. Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers. Eur J Clin Pharmacol. 2009.
- de Avelar CR, et al. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World J Gastroenterol. 2017.
- Parés A, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 1998.
- Fried MW, et al. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA. 2012.
- Li S, et al. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis. Ann Hepatol. 2024.
- Kawaguchi-Suzuki M, et al. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity. Drug Metab Dispos. 2014.
- Bi X, et al. Piperine enhances the bioavailability of silybin via inhibition of efflux transporters BCRP and MRP2. Phytomedicine. 2019.
- Abenavoli L, et al. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res. 2018.
Adapted from research by the Electric Tiger editorial team — read the original.